Aurora Cannabis (ACB) shares surged over 28% after President Trump praised CBD as a potential alternative to prescription drugs for seniors. The rally reflects optimism about federal policy changes, possibly rescheduling marijuana. ACB, deriving two-thirds of revenue from medical channels, stands to benefit. However, caution is advised as shares are no longer undervalued post-surge.

Read more at Yahoo Finance: Aurora Cannabis Is Spiking. Barchart Options Data Tells Us ACB Stock Could Be Headed Here Next.